Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: A Markov model decision analysis-Reference-Cited by-同舟云学术

Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: A Markov model decision analysis

Published:2009-09 Issue:3 Volume:198 Page:396-406
ISSN:0002-9610
Container-title:The American Journal of Surgery
language:en
Short-container-title:The American Journal of Surgery

Author:

Molinari Michele,Helton Scott

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference77 articles.

1. Epidemiology of primary liver cancer;Bosh;Semin Liver Dis,1999

2. Epidemiology of hepatocellular carcinoma;Munoz,1989

3. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

4. Hepatocellular carcinoma in Italian patients with cirrhosis;Colombo;N Engl J Med,1991

5. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis;Pateron;J Hepatol,1994

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thermal ablation versus liver resection for hepatocellular carcinoma in patients with cirrhosis: a systematic review and meta-analysis of propensity-score matched studies;Clinical and Experimental Medicine;2024-02-01

2. Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2023-01

3. Surgical resection versus radiofrequency ablation for early recurrent hepatocellular carcinoma;European Journal of Gastroenterology & Hepatology;2022-05-27

4. Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3cm) hepatocellular carcinoma;Clinical and Molecular Hepatology;2021-11-24

5. Cost–utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma;Future Oncology;2021-03